Adam Maeder

Stock Analyst at Piper Sandler

(0.07)
# 2113
Out of 5,243 analysts
125
Total ratings
55.38%
Success rate
-0.14%
Average return
20 Stocks
Name Action Price Target Current % Upside Ratings Updated
ResMed
Initiates Coverage On: Neutral
252
233.06 8.13% 1 Jan 10, 2025
Inari Medical
Maintains: Neutral
52 80
79.5 0.63% 7 Jan 7, 2025
Vicarious Surgical
Maintains: Neutral
12 11
13.9 -24.46% 6 Nov 13, 2024
Nevro
Maintains: Underweight
7 6
3.72 61.29% 15 Nov 12, 2024
Inspire Medical Syst...
Reiterates: Overweight
255 260
175.68 48% 13 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
73 70
70.89 -1.26% 12 Oct 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
495 538
577.36 -6.82% 17 Oct 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
131 133
111.39 19.4% 2 Oct 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
5 5
2.65 69.81% 3 Sep 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
20 21
13.83 51.84% 2 May 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
18 20
n/a n/a 6 May 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
290 360
n/a n/a 10 Apr 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
7 8
2.38 236.13% 1 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
15 20
9.86 102.84% 8 Mar 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
75 71
n/a n/a 8 Jan 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
25 30
17.53 71.14% 2 May 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
6 5
2.1 138.1% 2 Mar 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
10 18
7.78 131.36% 2 Jan 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
104 99
48.14 105.65% 3 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
9 11
n/a n/a 5 Jun 14, 2021